FDA’s OTC Monograph Division Head Recognizes Need To Speed Process
This article was originally published in The Rose Sheet
Executive Summary
Addressing industry stakeholders as a member of a CHPA conference panel, FDA’s OTC monograph division chief Scott Furness says the agency shares companies’ frustration with the sluggish pace of monograph finalization. However, he shares some good news on time and extent applications.